Chromium 4-hydroxyisoleucinate supplement for glucose uptake

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for managing diabetes, including lifestyle changes and medications, often fail to effectively improve glucose uptake and insulin resistance when used alone or in combination with natural products or herbs.

Innovation Solution

A dietary supplement containing chromium 4-hydroxyisoleucinate, formulated as a powder, liquid, gel, gum, or food product, which enhances blood glucose control and insulin resistance by primarily utilizing glucose transporter type 4 (GLUT4), and can be administered via various routes including oral, subcutaneous, intravenous, and intramuscular.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional diabetes management methods (lifestyle changes and medications) are used, then basic blood glucose control is achieved, but glucose uptake and insulin resistance improvement are insufficient

Engineering Contradiction:
Improveblood glucose control effectivenessVSAvoidglucose uptake improvement
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent changes the chemical parameter of the chromium compound from conventional forms to chromium 4-hydroxyisoleucinate, a specific coordination complex with improved biological activity. This parameter change enables both reliable blood glucose control and enhanced glucose uptake through GLUT4 activation, resolving the contradiction between control reliability and uptake productivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite chromium-amino acid complex (chromium 4-hydroxyisoleucinate) that combines the glucose tolerance factor properties of chromium with the insulin-sensitizing properties of hydroxylated amino acids. This composite material achieves synergistic effects, improving both blood glucose control reliability and glucose uptake efficiency simultaneously

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If natural products or herbs are used in combination with diabetes medications, then additional therapeutic benefits are sought, but effectiveness in improving insulin resistance remains inadequate

Engineering Contradiction:
Improvecombination therapy potentialVSAvoidinsulin resistance improvement
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

Chromium 4-hydroxyisoleucinate acts as an intermediary substance that mediates between natural products/herbs and diabetes medications. It enhances the insulin-sensitizing effects of natural products while being compatible with conventional medications, providing reliable insulin resistance improvement in combination therapy scenarios through its dual mechanism of GLUT4 activation and insulin potentiation

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS9795676B2Chromium 4-hydroxyisoleucinate compound methods for prepartion and use
Publication Date: 2017.10.24 MORRIS SHAYNE KENNETH

AI summary

A dietary supplement that may include chromium 4-hydroxyisoleucinate. The chromium 4-hydroxyisoleucinate may be provided in a molar ratio between 1:5 and 5:1 ligand to metal. The dietary supplement may be used to manage blood glucose levels, to improve insulin resistance, and to improve glucose uptake.